Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus

Molecular Pharmacology

Volumn 54, Issue 1, 1998, Pages 94-104

  Berg, Kelly A ^a   Maayani, Saul ^b   Goldfarb, Joseph ^b   Scaramellini, Clare ^c   Leff, Paul ^c   Clarke, William P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LYSERGIC ACID; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR;

ARACHIDONIC ACID METABOLISM; ARTICLE; DATA ANALYSIS; DRUG EFFICACY; ENZYME CONFORMATION; HYPOTHESIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR POTENTIAL; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS;

EID: 0031815337     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.1.94     Document Type: Article

References (39)

1. q/11. J Biol Chem 269:13733-13735.
2. 2C receptors: direct and indirect effects on ligand affinity mediated by the same locus. Mol Pharmacol 50:34-42.
3. B receptors to the same channels in hippocampus. Science (Washington DC) 234:1261-1265.
4. Berg KA, Clarke WP, Chen YB, Ebersole BJ, MacKay RDG, and Maayani S (1994a) 5-Hydroxytryptamine type 2A receptors regulate cAMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms. Mol Pharmacol 45:826-836.
5. Berg KA, Clarke WP, Sailstad C, Saltzman A, and Maayani S (1994b) Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems. Mol Pharmacol 46:477-485.
6. 1B-like receptor function via arachidonic acid metabolism. Mol Pharmacol 50:1017-1023.
7. 1C receptor agonist. J Pharmacol Exp Ther 258:891-896.
8. Costa T, Ogino Y, Munson PJ, Onaran HO, and Rodbard D (1992) Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol Pharmacol 41:549-560.
9. De Vivo M and Maayani S (1986) Characterization of the 5-hydroxytryptamine 1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J Pharmacol Exp Ther 238:248-253.
10. Exton JH (1994) Phosphatidylcholine breakdown and signal transduction. Biochim Biophys Acta 1212:26-42.
11. 2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc Natl Acad Sci USA 87:2187-2191.
12. i that amplifies ATP-mediated arachidonic acid release. Proc Natl Acad Sci USA 88:6477-6480.
13. Furchgott RF (1966) The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes, in Advances in Drug Research (Harper NJ and Simmonds AB, eds) pp 21-55, Academic Press, London.
14. Gether U, Lin S, and Kobilka BK (1995) Fluorescent labeling of purified β2 adrenergic receptor: evidence for ligand-specific conformational changes. J Biol Chem 270:28268-28275.
15. 1A receptor. Biochemistry 33:4283-4290.
16. Giles H, Lansdell SJ, Bolofo ML, Wilson HL, and Martin GR (1996) Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding. Br J Pharmacol 117:1119-1126.
17. 2 agonists or antagonists? Neuropsychopharmacology 3:509-517.
18. Guderman T, Kalkbrenner F, and Schultz G (1996) Diversity and selectivity of receptor-G protein interaction. Annu Rev Pharmacol Toxicol 36:429-459.
19. Harden TK, Boyer JL, and Nicholas RA (1995) P2-purinergic receptors: subtype-associated signaling responses and structure. Annu Rev Pharmacol Toxicol 35:541-579.
20. 2c receptor stimulates cyclic GMP formation in choroid plexus. J Neurochem 64:199-205.
21. Kenakin T (1995) Agonist-receptor efficacy II: agonist trafficking of receptor signals. Trends Pharmacol Sci 16:232-238.
22. Kenakin T (1996) The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev 48:413-463.
23. Kenakin T (1997) Pharmacologic Analysis of Drug-Receptor Interaction, 3rd ed. Lippincott-Raven, New York.
24. s complex: evidence for agonist-specific receptor states. Mol Pharmacol 52:144-154.
25. Leff P (1995) The two-state model of receptor activation. Trends Pharmacol Sci 16:89-97.
26. Leff P, Scaramellini C, Law C, and McKechnie K (1997) A three-state model of agonist action. Trends Pharmacol Sci 18:355-362.
27. Lucaites VL, Nelson DL, Wainscott DB, and Baez M (1996) Receptor subtype and density determine the coupling repertoire of the 5-HT2 receptor subfamily. Life Sci 59:1081-1095.
28. 11α equally and non-selectively. FEBS Lett 324:241-245.
29. Quick MW, Simon MI, Davidson N, Lester HA, and Aragay AM (1994) Differential coupling of G protein alpha subunits to seven-helix receptors expressed in Xenopus oocytes. J Biol Chem 269:30164-30172.
30. Rhee SG and Choi KDP (1992) Regulation of inositol phospholipid-specific phospholipase C isozymes. J Biol Chem 267:12393-12396.
31. Robb S, Cheek TR, Hannan FL, Hall LM, Midgley JM, and Evans PD (1994) Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems. EMBO J 13:1325-1330.
32. Samama P, Cotecchia S, Costa T, and Lefkowitz RJ (1993) A mutation-induced activated state of the β2-adrenergic receptor: extending the ternary complex model. J Biol Chem 268:4625-4636.
33. Sanders-Bush E, Burris KD, and Knoth K (1988) Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. J Pharmacol Exp Ther 246:924-928.
34. 11α, equally. Mol Pharmacol 46:1-7.
35. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, and Journot L (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature (Land) 365:170-175.
36. van Sande J, Raspé J, Perret J, Lejeune C, and Maenhaut C (1990) Thyrotropin activates both the cAMP and the PIP2 cascade in CHO cells expressing the human cDNA of the TSH receptor. Mol Cell Endocrinol 74:R1-R6.
37. Wagner JJ and Chavkin CI (1995) Neuropharmacology of endogenous opioid peptides, in Psychopharmacology: The Fourth Generation of Progress (Bloom FE and Kupfer DJ, eds) pp 519-529, Raven Press, New York.
38. 2 receptor: a mechanistic hypothesis from molecular dynamics simulations of the three-dimensional model of the receptor complexed to ligands. J Med Chem 36:934-938.
39. Zifa E and Fillion G (1992) 5-Hydroxytryptamine receptors. Pharmacol Rev 44:401-458.